|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Raymond James on March 2, 2021. The analyst firm set a price target for 3.50 expecting LPTX to rise to within 12 months (a possible 146.48% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.42 last updated Fri Jul 30 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Leap Therapeutics.
There is no upcoming split for Leap Therapeutics.
Leap Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.